Travere Therapeutics (TVTX)
NASDAQ:TVTX
Holding TVTX?
Track your performance easily

Travere Therapeutics (TVTX) Financial Statements

360 Followers

Travere Therapeutics Financial Overview

Travere Therapeutics's market cap is currently ―. The company's EPS TTM is $-4.838; its P/E ratio is -3.14; Travere Therapeutics is scheduled to report earnings on November 6, 2024, and the estimated EPS forecast is $-0.63. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 54.12M$ 41.37M$ 45.06M$ 37.09M$ 57.01M
Gross Profit$ 52.05M$ 39.87M$ 40.49M$ 35.81M$ 59.55M
EBIT$ -66.78M$ -67.76M$ -85.71M$ -86.43M$ -82.67M
EBITDA$ -56.43M$ -57.88M$ -76.22M-$ -72.09M
Net Income Common Stockholders$ -70.41M$ -136.06M$ -90.17M$ -89.24M$ -85.63M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 325.40M$ 441.04M$ 566.85M$ 634.64M$ 491.34M
Total Assets$ 551.12M$ 663.55M$ 788.91M$ 832.85M$ 736.43M
Total Debt$ 403.23M$ 404.02M$ 404.78M$ 405.48M$ 406.17M
Net Debt$ 77.83M$ -37.03M$ -162.07M$ -229.16M$ -85.17M
Total Liabilities$ 535.97M$ 589.48M$ 588.10M$ 553.08M$ 619.94M
Stockholders Equity$ 15.15M$ 74.07M$ 200.81M$ 279.77M$ 116.48M
Cash Flow-
Free Cash Flow$ -52.24M$ -125.47M$ -76.00M-$ -72.50M
Operating Cash Flow$ -40.24M$ -119.00M$ -70.47M$ -59.13M$ -69.30M
Investing Cash Flow$ 28.61M$ 104.90M$ -16.95M$ 133.32M$ -23.55M
Financing Cash Flow$ 782.00K$ -525.00K$ 124.00K$ -634.00K$ 2.27M
Currency in USD

Travere Therapeutics Earnings and Revenue History

Travere Therapeutics Debt to Assets

Travere Therapeutics Cash Flow

Travere Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis